logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Thinking About Cognition Concepts Targets And Therapeutics Solvay Pharmaceutical Conferences Volume 5 1st Edition C G Kruse

  • SKU: BELL-2195912
Thinking About Cognition Concepts Targets And Therapeutics Solvay Pharmaceutical Conferences Volume 5 1st Edition C G Kruse
$ 31.00 $ 45.00 (-31%)

4.8

64 reviews

Thinking About Cognition Concepts Targets And Therapeutics Solvay Pharmaceutical Conferences Volume 5 1st Edition C G Kruse instant download after payment.

Publisher: IOS Press
File Extension: PDF
File size: 1.34 MB
Pages: 144
Author: C. G. Kruse, H. Y. Meltzer, C. Sennef, S. V. Van De Witte
ISBN: 1586037021, 9781586037024
Language: English
Year: 2006
Edition: 1

Product desciption

Thinking About Cognition Concepts Targets And Therapeutics Solvay Pharmaceutical Conferences Volume 5 1st Edition C G Kruse by C. G. Kruse, H. Y. Meltzer, C. Sennef, S. V. Van De Witte 1586037021, 9781586037024 instant download after payment.

100 Years after the discovery of Alzheimer's disease, neurological diseases and psychiatric disorders represent the largest and fastest growing unmet medical market with 2 billion affected people worldwide. Life expectancy of humans continues to increase, and the world population is aging. Advanced age may lead to deterioration of cognitive functions of the brain. There seems to be consensus that on the background of aging, several factors may render humans prone to dementia. Psychiatric and neurological disorders such as schizophrenia, bipolar disorder or Parkinson's disease may contribute to development of dementia. More people today are looking for help regarding their learning and memory capabilities. Although increasing knowledge on neuronal networks is transforming our view of the human brain and its function and we understand psychiatric and neurological diseases better today than ever before, novel therapies are needed to respond to the growing demand of patients for assistance with memory loss and learning impairment. In fact, it is expected that novel therapies aiming at the processing of amyloid, or at activation of glutamatergic or nicotinergic systems will demonstrate adequate efficacy in improving learning and memory disturbances. This publication stands as a comprehensive overview of the cellular and molecular mechanisms underlying the development of cognitive impairment. It integrates discoveries concerning dementia, such as mild cognitive impairment and Alzheimer's disease associated dementia, vascular dementia, retardation syndromes, and psychiatric and neurological disorders related cognitive impairments. This book will be useful to physicians, biologists, and those pursuing an interest or concerned with memory impairment.IOS Press is an international science, technical and medical publisher of high-quality books for academics, scientists, and professionals in all fields. Some of the areas we publish in: -Biomedicine -Oncology -Artificial intelligence -Databases and information systems -Maritime engineering -Nanotechnology -Geoengineering -All aspects of physics -E-governance -E-commerce -The knowledge economy -Urban studies -Arms control -Understanding and responding to terrorism -Medical informatics -Computer Sciences

Related Products